oasis 1 oral semaglutide 50 mg obesity nejm 2023 of #semaglutide daily was associated with body weight reduction and improved cardiometabolic risk factors in East Asian adults with overweight or #obesity, with or without type 2 #diabetes. https://ja.ma/41sPiYj oral semaglutide 50 mg obesity
Description
The terms, in plain language Semaglutide: the active drug in both Ozempic (diabetes) and Wegovy (weight management)
The medication that silences food noise seems to mute other emotions too
Vandenbeuch A, Anderson CB, Parnes J, Enjyoji K, Robson SC, Finger TE, Kinnamon SC
DA Meeting News
My face feels amazing
